跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Laberfen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Laberfen
Approved
STANDARD
Laberfen
Drugmaker's Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9148de700c67f589
Company
Drugmaker's Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
9148de700c67f589
Drug Approval Philippines Name
Laberfen
Product Name
Laberfen
Registration Number
DRP-5635
Brand Name
Laberfen
Generic Name
Ibuprofen
Dosage Form
Tablet
Dosage Strength
400 mg
Manufacturer
Drugmaker's Laboratories, Inc.
Trader
Vonwelt Inc.
Issuance Date
29 May 2023
Expiry Date
19 August 2028
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9148de700c67f589
Type
Standard
Back to Philippines FDA Approvals